Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04877366 · ClinicalTrials.gov registry record · NA
Evaluate Effects of Sprinkled Format REDUCOSE in a Carbohydrate-rich, Mixed Meal on Post-prandial Glycemia
A NA study of Dietary Supplement, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT04877366: Completed NA study of Dietary Supplement, sponsored by Société des Produits Nestlé (SPN).
NCT04877366 is a NA study of Dietary Supplement that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 30 participants, below the 46-participant average among 5 other Dietary Supplement trials with a reported enrollment target (35% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04877366, a NA study of Dietary Supplement, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a mechanistic, single-center, double-blind, placebo- and active-controlled, three-time-period, crossover study to evaluate the effect of sprinkled format REDUCOSE compared to placebo (double-blind; confirmative) and active control (open-label; acarbose - explorative) on post prandial glycemia in Asian patients with type 2 diabetes.
Primary Outcome
Incremental area under the curve post-prandial glycemic excursion (iAUC 0-1h, iAUC 0-2h, iAUC 0-3h).
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Dietary Supplement: Sprinkled Format REDUCOSE.
- OTHER Reference control
- OTHER Active comparator
Study Locations (2)
California
- Orange County Research Center - Tustin
Other
- Temasek Polytechnic - Singapore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-07-21 |
| Est. Completion | 2021-12-01 |
| Phase | NA |
What the finished NCT04877366 record still lists
NCT04877366 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 46-participant average among 5 other Dietary Supplement trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Dietary Supplement appearing as the primary indexed condition, and to 3 interventions - of which Dietary Supplement: Sprinkled Format REDUCOSE. is the first listed.
NCT04877366 reports a single indexed study location in California, Other.
Frequently Asked Questions
What is clinical trial NCT04877366 about?
NCT04877366 is a clinical study titled "Evaluate Effects of Sprinkled Format REDUCOSE in a Carbohydrate-rich, Mixed Meal on Post-prandial Glycemia". This is a mechanistic, single-center, double-blind, placebo- and active-controlled, three-time-period, crossover study to evaluate the effect of sprinkled format REDUCOSE compared to placebo (double-blind; confirmative) and active control (open-label; acarbose - explorative) on post prandial glycemi...
What is the current status of trial NCT04877366?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-07-21. Estimated completion is 2021-12-01.
What conditions does trial NCT04877366 study?
This clinical trial studies the following conditions: Dietary Supplement.
What interventions are being tested in trial NCT04877366?
The interventions under investigation include: Dietary Supplement: Sprinkled Format REDUCOSE. (DIETARY_SUPPLEMENT), Reference control (OTHER), Active comparator (OTHER).
Who is sponsoring clinical trial NCT04877366?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04877366 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dietary Supplement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Breathing Training and Nitrate on Exercise at Simulated Altitude
RECRUITING · NA
-
Microalgae Extract Phaeosol Combined to Exercise in Healthy Overweight Women : Efficacy on Body Weight Management
COMPLETED · NA
-
A Study to Evaluate the Effects of Pre-Meal Whey Protein Microgels Administration on Post-Prandial Glycemic Response.
COMPLETED · NA
-
Understanding the Efficacy of Dietary Supplement on Fungal Mycobiota in Healthy Volunteers: A Pilot Study
RECRUITING · Phase 4
-
Efficacy of Fish Oil or Olive Oil Supplementation on the Health Effects of Ozone Exposure in Healthy Young Subjects
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI